These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 14971519

  • 1. Immune response of intradermal hepatitis B vaccination at lower dose versus intramuscular vaccination at double standard dose in predialytic chronic renal failure patients.
    Somboonsilp W, Eiam-Ong S, Tungsanga K, Tirawatanapong T.
    J Med Assoc Thai; 2003 Dec; 86(12):1122-7. PubMed ID: 14971519
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of intradermal hepatitis B vaccination compared to intramuscular vaccination in hemodialysis patients.
    Chanchairujira T, Chantaphakul N, Thanwandee T, Ong-Ajyooth L.
    J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S33-40. PubMed ID: 17044452
    [Abstract] [Full Text] [Related]

  • 3. The evaluation of the effectiveness of multiple dose intradermal hepatitis B re-vaccination in hemodialyzed patients not responding to standard method of immunization.
    Radziszewski A, Gajda M, Pituch-Noworolska A, Drozdz M, Kraśniak A, Kaczmarczyk I, Hołyś S, Zurowski J, Sydor A, Sułowicz W.
    Przegl Lek; 2007 Aug; 64(7-8):470-5. PubMed ID: 18409347
    [Abstract] [Full Text] [Related]

  • 4. Comparative immunogenicity of 2 recombinant hepatitis B vaccines (GeneVac-B and Engerix-B) in adult patients with chronic renal failure.
    Rajapurkar MM, Gang S, Dabhi M, Kulkarni PS.
    J Nephrol; 2007 Aug; 20(5):596-601. PubMed ID: 17918146
    [Abstract] [Full Text] [Related]

  • 5. Intramuscular versus low-dose intradermal hepatitis B vaccine. Assessment by humoral and cellular immune response to hepatitis B surface antigen.
    Frazer IH, Jones B, Dimitrakakis M, Mackay IR.
    Med J Aust; 1987 Mar 02; 146(5):242-5. PubMed ID: 2950303
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [A five-year observation on efficacy of revaccination in children of non-response to hepatitis B vaccine].
    Zhuang GH, Yan H, Wang XL, Wu Q, Wang LR, Gao HY.
    Zhonghua Yu Fang Yi Xue Za Zhi; 2006 Jan 02; 40(1):8-12. PubMed ID: 16620590
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Comparison of intramuscular and intradermal applications of hepatitis B vaccine in hemodialysis patients.
    Karahocagil MK, Buzgan T, Irmak H, Karsen H, Akdeniz H, Akman N.
    Ren Fail; 2006 Jan 02; 28(7):561-5. PubMed ID: 17035164
    [Abstract] [Full Text] [Related]

  • 13. A randomised controlled trial of intradermal hepatitis B vaccination and augmentation of response with erythropoietin.
    Anandh U, Thomas PP, Shastry JC, Jacob CK.
    J Assoc Physicians India; 2000 Nov 02; 48(11):1061-3. PubMed ID: 11310381
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of low dose intradermal hepatitis B vaccine: results of a randomized trial among health care workers.
    Das HS, Sawant P, Shirhatti RG, Vyas K, Vispute S, Dhadphale S, Patrawalla V, Desai N.
    Trop Gastroenterol; 2002 Nov 02; 23(3):120-1. PubMed ID: 12693152
    [Abstract] [Full Text] [Related]

  • 15. A comparison of responsiveness to hepatitis B vaccination in patients on hemodialysis and peritoneal dialysis.
    Liu YL, Kao MT, Huang CC.
    Vaccine; 2005 Jun 10; 23(30):3957-60. PubMed ID: 15917117
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Antibody response to hepatitis B vaccine in end-stage renal disease patients.
    Chow KM, Law MC, Leung CB, Szeto CC, Li PK.
    Nephron Clin Pract; 2006 Jun 10; 103(3):c89-93. PubMed ID: 16534237
    [Abstract] [Full Text] [Related]

  • 18. Systematic review of the efficacy and safety of intradermal versus intramuscular hepatitis B vaccination in end-stage renal disease population unresponsive to primary vaccination series.
    Yousaf F, Gandham S, Galler M, Spinowitz B, Charytan C.
    Ren Fail; 2015 Aug 10; 37(7):1080-8. PubMed ID: 26258528
    [Abstract] [Full Text] [Related]

  • 19. Cellular and humoral immune responses induced by intradermal or intramuscular vaccination with the major hepatitis B surface antigen.
    Rahman F, Dahmen A, Herzog-Hauff S, Böcher WO, Galle PR, Löhr HF.
    Hepatology; 2000 Feb 10; 31(2):521-7. PubMed ID: 10655280
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.